A Phase II Sequential Dose-escalation Study Evaluating the Safety and Feasibility of Allogenlc Umbillcal Cord Derived Mesenchymal Stromal Cells for the Treatment of Adults w/ Treatment Refractory Lupus

Project: Research project

Project Details

Description

Northwestern University will be a clinical site for a planned clinical trial and will enroll 13 participants in the trial by interacting with the trial PI and co-investigators and complete all CRFs, comply with data management and analysis plans for the trial and also complete site specific tasks such as the local IRB and research unit applications, budget and clean cell facility utilization.
StatusActive
Effective start/end date10/1/199/30/22

Funding

  • Medical University of South Carolina (A00-3635-S009)
  • Lupus Foundation of America, Inc. (A00-3635-S009)

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.